SIAH3: A Potential Drug Target and Biomarker for Ubiquitin-Proteasome Systems

Target Name: SIAH3

NCBI ID: G283514

SIAH3

SIAH3: A Potential Drug Target and Biomarker for Ubiquitin-Proteasome Systems

Introduction

The ubiquitin-proteasome (UPS) system is a critical intracellular waste management system that regulates protein degradation. Ubiquitin is a small protein that plays a central role in this system by covalently linking target proteins to its polyhistidine residue, which can interact with a variety of factors to determine protein stability and localization. The Siah E3 ubiquitin protein ligase family member 3 (SIAH3) is a protein that belongs to this family and has been identified as a potential drug target and biomarker.

In this article, we will provide an overview of SIAH3, including its structure and function, its potential as a drug target, and its potential as a biomarker for various diseases.

Structure and Function

SIAH3 is a 14 kDa protein that is expressed in a variety of tissues, including muscle, liver, and brain. It is composed of an N-terminal transmembrane domain, a coiled-coil domain, and an C-terminal protein domain. The transmembrane domain is responsible for the protein's solute transport and membrane interactions, the coiled-coil domain is responsible for the protein's stability and interactions with other proteins, and the C-terminal protein domain is responsible for the protein's catalytic activity.

SIAH3 plays a critical role in the UPS by covalently linking target proteins to its polyhistidine residue. This process is known as ubiquitination and is a critical step in the UPS. Ubiquitination involves the transfer of a ubiquitin molecule from one protein to another, which can modulate protein stability, localization, and interactions with other proteins.

SIAH3 has been shown to play a role in a variety of cellular processes, including cell signaling, DNA damage repair, and inflammation. For example, SIAH3 has been shown to be involved in the regulation of the T-cell response to infection and cancer. It has also been shown to play a role in the regulation of the cell cycle and the apoptosis process.

Potential Drug Target

SIAH3 has been identified as a potential drug target due to its involvement in the UPS and its ability to modulate protein stability and localization. Several studies have shown that inhibiting SIAH3 activity can lead to the downregulation of target proteins, such as p53, which is a critical regulator of cell growth and apoptosis.

In addition, SIAH3 has been shown to play a role in the regulation of the cell cycle and the apoptosis process. inhibiting SIAH3 activity has been shown to prolong the cell cycle, increase the density of apoptotic cells and promote the apoptosis process.

Potential Biomarkers

SIAH3 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Several studies have shown that the expression of SIAH3 is altered in these diseases and that inhibiting SIAH3 activity may be a promising strategy for the development of new treatments for these diseases.

Conclusion

SIAH3 is a protein that plays a critical role in the UPS and has been identified as a potential drug target and biomarker for several diseases. Its involvement in the regulation of the UPS, its ability to modulate protein stability and localization, and its potential as a biomarker for several diseases make it an attractive target for future research. Further studies are needed to fully understand the role of SIAH3 in cellular processes and its potential as a drug

Protein Name: Siah E3 Ubiquitin Protein Ligase Family Member 3

Functions: Negative regulator of PRKN translocation to damaged mitochondria. Acts probably by destabilizing PINK1 protein, hence inhibiting PRKN targeting to dysfunctional depolarized mitochondria

The "SIAH3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SIAH3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets